The pursuit of outperformance leads many investors to carefully choose individual stocks. Picking the right ones can be a game-changer for growing your wealth.
3 Tiny Stocks Primed to Explode
The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.
We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.
Click here for full details and to join for free
Sponsored
After finishing at $110.33 in the prior trading day, Novartis AG ADR (NYSE: NVS) closed at $110.53, up 0.18%. In other words, the price has increased by $0.18 from its previous closing price. On the day, 1.14 million shares were traded. NVS stock price reached its highest trading level at $110.62 during the session, while it also had its lowest trading level at $110.01.
Ratios:
Our goal is to gain a better understanding of NVS by taking a closer look at its different ratios. It provided that stocks Price–to–Cash (P/C) ratio for the trailing twelve months (TTM) is standing at 22.18 whereas its Price-to-Free Cash Flow (P/FCF) for the term is 17.01. For the most recent quarter (mrq), Quick Ratio is recorded 0.71 and its Current Ratio is at 0.90. In the meantime, Its Debt-to-Equity ratio is 0.69 whereas as Long-Term Debt/Eq ratio is at 0.47.
Upgrades & Downgrades
In addition, analysts’ ratings and any changes thereto give investors an idea of the stock’s future direction. In the most recent recommendation for this company, Goldman on May 30, 2024, initiated with a Buy rating and assigned the stock a target price of $120.
On February 23, 2024, BMO Capital Markets started tracking the stock assigning a Market Perform rating and target price of $114.
On January 23, 2024, Morgan Stanley started tracking the stock assigning a Equal-Weight rating and target price of $114.Morgan Stanley initiated its Equal-Weight rating on January 23, 2024, with a $114 target price.
Valuation Measures:
Investors should consider key stock statistics when deciding whether to invest or divest. In the wake of the recent closing price, NVS now has a Market Capitalization of 225526513664 and an Enterprise Value of 243188121600. As of this moment, Novartis’s Price-to-Earnings (P/E) ratio for their current fiscal year is 15.00, and their Forward P/E ratio for the next fiscal year is 13.87. The expected Price-to-Earnings-to-Growth (PEG) calculation for the next 5 years is 1.44. For the stock, the TTM Price-to-Sale (P/S) ratio is 4.44 while its Price-to-Book (P/B) ratio in mrq is 5.68. Its current Enterprise Value per Revenue stands at 5.095 whereas that against EBITDA is 12.837.
Stock Price History:
The Beta on a monthly basis for NVS is 0.58, which has changed by 0.07081962 over the last 52 weeks, in comparison to a change of 0.24125004 over the same period for the S&P500. Over the past 52 weeks, NVS has reached a high of $112.48, while it has fallen to a 52-week low of $91.70. The 50-Day Moving Average of the stock is 6.01%, while the 200-Day Moving Average is calculated to be 10.40%.
Shares Statistics:
The stock has traded on average 1.44M shares per day over the past 3-months and 1350790 shares per day over the last 10 days, according to various share statistics. A total of 2.04B shares are outstanding, with a floating share count of 1.96B. Insiders hold about 0.00% of the company’s shares, while institutions hold 7.14% stake in the company. Shares short for NVS as of 1719532800 were 6283959 with a Short Ratio of 4.34, compared to 1717113600 on 3924691.
Dividends & Splits
In the trailing 12 months, NVS’s forward annual dividend rate was 3.919, compared to 3.74 this year. Against a Trailing Annual Dividend Yield of 0.03552071The stock’s 5-year Average Dividend Yield is 3.61. The current Payout Ratio is 44.73% for NVS, which recently paid a dividend on 2024-03-07 with an ex-dividend date of 1709769600. Stock splits for the company last occurred on 2019-04-09 when the company split stock in a 1116:1000 ratio.
